Very high prevalence of hepatitis C virus genotype 6 variants in southern vietnam: Large-scale survey based on sequence determination

Japanese Journal of Infectious Diseases

Volumn 64, Issue 6, 2011, Pages 537-539

  Pham, Van H ^a,b   Nguyen, Huyen D P ^b   Ho, Phat T ^c   Banh, Dien V ^c   Pham, Hoa L T ^d   Pham, Phiet H ^e   Lu, Ling ^f   Abe, Kenji ^a,b,g  

^a UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^b Nam Khoa Biotek Laboratory   (Viet Nam)

^c CHO RAY HOSPITAL   (Viet Nam)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e Saigon Liver Clinic   (Viet Nam)

^f UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^g NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 6; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; SPECIES DISTRIBUTION; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 82355168987     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.64.537     Document Type: Article

References (13)

1. Simmonds, P., Bukh, J., Combet, C., et al. (2005): Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology, 42, 962-973.
2. McHutchison, J.G., Gordon, S.C., Schiff, E.R., et al. (1998): Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med., 339, 1485-1492.
3. Fried, M.W., Hadziyannis, S.J., Shiffman, M.L., et al. (2011): Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection. J. Hepatol., 55, 69-75.
4. Roman, F., Hawotte, K., Struck, D., et al. (2008): Hepatitis C virus genotypes distribution and transmission risk factors in Lux- embourg from 1991 to 2006. World J. Gastroenterol., 28, 1237-1243.
5. Nguyen, N.H., Vutien, P., Trinh, H.N., et al. (2010) Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol. Int., 4, 523-529.
6. Lu, L., Murphy, D., Li, C., et al. (2008): Complete genomes of three subtype 6t isolates and analysis of many novel HCV variants within genotype 6. J. Gen. Virol., 89, 444-452.
7. Zylberberg, H., Chaix, M.L. and Brechot, C. (2000): Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann. Intern. Med., 132, 845-846.
8. Silini, E., Bono, F., Cividini, A., et al. (1995): Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology, 21, 285-290.
9. Abe, K., Edamoto, Y., Park, Y.N., et al. (1998): In situ detection of hepatitis B, C and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology, 28, 568-572.
10. Hui, C.K., Yuen, M.F., Sablon, E., et al. (2003): Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. J. Infect. Dis., 187, 1071-1074.
11. Fung, J., Lai, C.L., Hung, I., et al. (2008): Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J. Infect. Dis., 198, 808-812.
12. Seto, W.K., Lai, C.L., Fung, J., et al. (2010): Natural history of chronic hepatitis C: genotype 1 versus genotype 6. J. Hepatol., 53, 444-448.
13. Chao, D.T., Abe, K. and Nguyen, M.H. (2011): Systematic review: epidemiology of hepatitis C genotype 6 and its management. Aliment. Pharmacol. Ther., 34, 286-296.